Hall SD - Search Results

1

Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.

Mäenpää J, Hall SD, Ring BJ, Strom SC, Wrighton SA. Mäenpää J, et al. Among authors: hall sd. Pharmacogenetics. 1998 Apr;8(2):137-55. Pharmacogenetics. 1998. PMID: 10022752

2

Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.

Hall SD, Hamman MA, Rettie AE, Wienkers LC, Trager WF, Vandenbranden M, Wrighton SA. Hall SD, et al. Drug Metab Dispos. 1994 Nov-Dec;22(6):975-8. Drug Metab Dispos. 1994. PMID: 7895619 No abstract available.

3

Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.

Gorski JC, Jones DR, Wrighton SA, Hall SD. Gorski JC, et al. Among authors: hall sd. Biochem Pharmacol. 1994 Jul 5;48(1):173-82. doi: 10.1016/0006-2952(94)90237-2. Biochem Pharmacol. 1994. PMID: 8043020

4

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

Gorski JC, Hall SD, Jones DR, VandenBranden M, Wrighton SA. Gorski JC, et al. Among authors: hall sd. Biochem Pharmacol. 1994 Apr 29;47(9):1643-53. doi: 10.1016/0006-2952(94)90543-6. Biochem Pharmacol. 1994. PMID: 8185679

5

Bimodal distribution of renal cytochrome P450 3A activity in humans.

Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, Hall SD. Haehner BD, et al. Among authors: hall sd. Mol Pharmacol. 1996 Jul;50(1):52-9. Mol Pharmacol. 1996. PMID: 8700118

6

Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.

Gorski JC, Jones DR, Wrighton SA, Hall SD. Gorski JC, et al. Among authors: hall sd. Xenobiotica. 1997 Mar;27(3):243-56. doi: 10.1080/004982597240578. Xenobiotica. 1997. PMID: 9141232

7

Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

Hamman MA, Thompson GA, Hall SD. Hamman MA, et al. Among authors: hall sd. Biochem Pharmacol. 1997 Jul 1;54(1):33-41. doi: 10.1016/s0006-2952(97)00143-3. Biochem Pharmacol. 1997. PMID: 9296349

8

Autoactivation and activation of the cytochrome P450s.

Ekins S, Ring BJ, Binkley SN, Hall SD, Wrighton SA. Ekins S, et al. Among authors: hall sd. Int J Clin Pharmacol Ther. 1998 Dec;36(12):642-51. Int J Clin Pharmacol Ther. 1998. PMID: 9877001

9

Molecular and physical mechanisms of first-pass extraction.

Hall SD, Thummel KE, Watkins PB, Lown KS, Benet LZ, Paine MF, Mayo RR, Turgeon DK, Bailey DG, Fontana RJ, Wrighton SA. Hall SD, et al. Drug Metab Dispos. 1999 Feb;27(2):161-6. Drug Metab Dispos. 1999. PMID: 9929497 Review.

10

Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.

Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, Hall SD. Jones DR, et al. Among authors: hall sd. J Pharmacol Exp Ther. 1999 Sep;290(3):1116-25. J Pharmacol Exp Ther. 1999. PMID: 10454485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters